These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20169751)

  • 1. Efficacy of a genotype 2 Newcastle disease vaccine (Avinew) against challenge with highly virulent genotypes 5d and 3d.
    Bwala DG; Abolnik C; van Wyk A; Cornelius E; Bisschop SP
    J S Afr Vet Assoc; 2009 Sep; 80(3):174-8. PubMed ID: 20169751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the distribution of lentogenic vaccine and virulent Newcastle disease virus antigen in the oviduct of SPF and commercial hen using immunohistochemistry.
    Bwala DG; Clift S; Duncan NM; Bisschop SP; Oludayo FF
    Res Vet Sci; 2012 Aug; 93(1):520-8. PubMed ID: 21774952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
    Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
    Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field vaccinated chickens with low antibody titres show equally insufficient protection against matching and non-matching genotypes of virulent Newcastle disease virus.
    Dortmans JC; Venema-Kemper S; Peeters BP; Koch G
    Vet Microbiol; 2014 Aug; 172(1-2):100-7. PubMed ID: 24894134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
    Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
    Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newcastle disease virus outbreaks: vaccine mismatch or inadequate application?
    Dortmans JC; Peeters BP; Koch G
    Vet Microbiol; 2012 Nov; 160(1-2):17-22. PubMed ID: 22655976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective antibody response produced by the chickens vaccinated with green coloured thermostable Newcastle disease virus.
    Wambura PN
    Trop Anim Health Prod; 2009 Feb; 41(2):149-52. PubMed ID: 18566908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
    Wajid A; Basharat A; Bibi T; Rehmani SF
    Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
    Liu H; de Almeida RS; Gil P; Majó N; Nofrarías M; Briand FX; Jestin V; Albina E
    Vaccine; 2018 Jun; 36(27):3917-3925. PubMed ID: 29843999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental vaccination of SPF chickens against Newcastle disease using the method of coated-millet vaccine from a thermotolerant variant of the LaSota virus].
    Nguyen-Ba-Vy
    Rev Elev Med Vet Pays Trop; 1994; 47(4):357-60. PubMed ID: 7770658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The resistance of meat chickens vaccinated by aerosol with a live V4 Newcastle disease virus vaccine in the field to challenge with a velogenic Newcastle disease virus.
    Bell IG; Nicholls PJ; Norman C; Ideris A; Cross GM
    Aust Vet J; 1991 Mar; 68(3):97-101. PubMed ID: 2043098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated Challenge with Virulent Newcastle Disease Virus Does Not Decrease the Efficacy of Vaccines.
    Taylor TL; Miller PJ; Olivier TL; Montiel E; Cardenas Garcia S; Dimitrov KM; Williams-Coplin D; Afonso CL
    Avian Dis; 2017 Jun; 61(2):245-249. PubMed ID: 28665733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogeny, pathogenicity and transmissibility of a genotype XII Newcastle disease virus in chicken and goose.
    Xiang B; Chen R; Liang J; Chen L; Lin Q; Sun M; Kang Y; Ding C; Liao M; Xu C; Ren T
    Transbound Emerg Dis; 2020 Jan; 67(1):159-170. PubMed ID: 31432620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.